Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Veterinary Services Market 

5.1. COVID-19 Landscape: Veterinary Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Veterinary Services Market, By Service Type

8.1. Veterinary Services Market, by Service Type, 2024-2033

8.1.1. Diagnostic tests and imaging

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Physical health monitoring

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Surgery

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Dessert

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Veterinary Services Market, By Animal Type

9.1. Veterinary Services Market, by Animal Type, 2024-2033

9.1.1. Production

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Poultry

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Swine

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Cattle

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Sheep & Goats

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Fish

9.1.6.1. Market Revenue and Forecast (2021-2033)

9.1.7. Companion

9.1.7.1. Market Revenue and Forecast (2021-2033)

9.1.8. Dogs

9.1.8.1. Market Revenue and Forecast (2021-2033)

9.1.9. Cats

9.1.9.1. Market Revenue and Forecast (2021-2033)

9.1.10. Horses

9.1.10.1. Market Revenue and Forecast (2021-2033)

9.1.11. Others

9.1.11.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Veterinary Services Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.1.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.1.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.2.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.2.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.3.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.3.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.4.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.4.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.5.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

10.5.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

Chapter 11. Company Profiles

11.1. Merck Animal Health

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Ceva Sante Animale

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Vetoquinol S.A.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Zoetis

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Boehringer Ingelheim GmbH

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Elanco

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Nutreco N.V.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Virbac

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Kindred Biosciences, Inc.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Biogenesis Bago

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms